Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Periodicals
Trump to order government to buy certain drugs from U.S., USA Today says » 10:12
08/06/20
08/06
10:12
08/06/20
10:12
JNJ

Johnson & Johnson

$148.29 /

-0.1 (-0.07%)

, LLY

Eli Lilly

$154.75 /

+0.36 (+0.23%)

, MRK

Merck

$81.48 /

-0.13 (-0.16%)

, PFE

Pfizer

$38.73 /

+0.28 (+0.73%)

, SNY

Sanofi

$51.41 /

-0.27 (-0.52%)

, AZN

AstraZeneca

$56.22 /

+0.3 (+0.54%)

, GSK

GlaxoSmithKline

$41.04 /

-0.17 (-0.41%)

, NVS

Novartis

$83.51 /

+0.07 (+0.08%)

, RHHBY

Roche

$0.00 /

+ (+0.00%)

, BMY

Bristol-Myers

$61.67 /

+1.98 (+3.32%)

President Donald Trump…

President Donald Trump will sign an executive order mandating the federal government to buy certain drugs from U.S. manufacturers rather than foreign companies, USA Today's Michael Collins reports, citing officials. The order, which will be signed at Whirlpool's (WHR) manufacturing facility in Ohio, requires the government to develop a list of "essential" medicines and purchase them as well as other medical supplies from the U.S. Publicly traded companies in the space include AstraZeneca (AZN), Bristol-Myers (BMY), Eli Lilly (LLY), GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Pfizer (PFE), Roche (RHHBY) and Sanofi (SNY). Reference Link

ShowHide Related Items >><<
SNY Sanofi
$51.41 /

-0.27 (-0.52%)

RHHBY Roche
$0.00 /

+ (+0.00%)

PFE Pfizer
$38.73 /

+0.28 (+0.73%)

NVS Novartis
$83.51 /

+0.07 (+0.08%)

MRK Merck
$81.48 /

-0.13 (-0.16%)

LLY Eli Lilly
$154.75 /

+0.36 (+0.23%)

JNJ Johnson & Johnson
$148.29 /

-0.1 (-0.07%)

GSK GlaxoSmithKline
$41.04 /

-0.17 (-0.41%)

BMY Bristol-Myers
$61.67 /

+1.98 (+3.32%)

AZN AstraZeneca
$56.22 /

+0.3 (+0.54%)

JNJ Johnson & Johnson
$148.29 /

-0.1 (-0.07%)

07/30/20 BofA
BofA says hard to compare Moderna COVID data to competing preclinical data
07/29/20 Laidlaw
Curis initiated with a Buy at Laidlaw
07/17/20 Goldman Sachs
J&J valuation discount to S&P 500 'too wide,' says Goldman Sachs
07/17/20 Citi
Johnson & Johnson price target raised to $170 from $165 at Citi
LLY Eli Lilly
$154.75 /

+0.36 (+0.23%)

07/31/20 Barclays
Eli Lilly earnings selloff 'meaningful over-reaction,' says Barclays
07/15/20 H.C. Wainwright
Blueprint Medicines price target raised to $110 from $66 at H.C. Wainwright
07/14/20 Baird
Blueprint Medicines price target raised to $100 from $90 at Baird
07/14/20 Raymond James
Blueprint Medicines price target raised to $106 from $95 at Raymond James
MRK Merck
$81.48 /

-0.13 (-0.16%)

08/04/20 Piper Sandler
Merck deal sparks interest in GLP-1:glucagon agonists, says Piper Sandler
08/03/20
Fly Intel: Top five analyst upgrades
08/03/20 Goldman Sachs
Merck upgraded to Buy from Neutral at Goldman Sachs
PFE Pfizer
$38.73 /

+0.28 (+0.73%)

08/03/20 Jefferies
Moderna's Phase 3 data on COVID vaccine could come by October, says Jefferies
07/30/20 Morgan Stanley
Pfizer price target raised to $42 from $36 at Morgan Stanley
07/30/20 Mizuho
Pfizer price target raised to $43 from $38 at Mizuho
SNY Sanofi
$51.41 /

-0.27 (-0.52%)

07/31/20 JPMorgan
Sanofi price target raised to EUR 106 from EUR 103 at JPMorgan
07/20/20 BMO Capital
Immunic initiated with an Outperform at BMO Capital
07/08/20 Piper Sandler
Piper upgrades Kiadis on 'platform validating' Sanofi deal
07/06/20 Citi
BioMarin price target raised to $148 from $105 at Citi
AZN AstraZeneca
$56.22 /

+0.3 (+0.54%)

07/31/20 Barclays
Barclays backs Overweight on AstraZeneca after Q2 results
07/29/20 Barclays
AstraZeneca price target raised to 9,300 GBp from 9,200 GBp at Barclays
GSK GlaxoSmithKline
$41.04 /

-0.17 (-0.41%)

07/31/20 Barclays
Barclays backs Underweight on GSK after 'challenging' Q2
07/30/20 Roth Capital
Roth Capital bullish on Ideaya as GSK highlights synthetic lethality pipeline
07/13/20 UBS
UBS reiterates Buy on GSK as FDA belantamab docs are out
07/13/20 JPMorgan
Ideaya upgraded to Overweight on recent pullback at JPMorgan
NVS Novartis
$83.51 /

+0.07 (+0.08%)

07/28/20 Morgan Stanley
Novartis price target raised to CHF 93 from CHF 91 at Morgan Stanley
07/01/20 Piper Sandler
Amgen appeal rules in favor of patent validity, says Piper Sandler
07/01/20 Jefferies
Amgen win on Enbrel patent removes key overhang, says Jefferies
07/01/20 Goldman Sachs
Global Blood Therapeutics upgraded to Buy from Neutral at Goldman Sachs
RHHBY Roche
$0.00 /

+ (+0.00%)

07/29/20 UBS
Roche price target raised to CHF 390 from CHF 380 at UBS
07/29/20 Morgan Stanley
Roche price target raised to CHF 375 from CHF 370 at Morgan Stanley
07/24/20 Credit Suisse
Credit Suisse backs Neutral on Roche after H1 results
07/24/20 UBS
Roche Q2 sales weak but recovery in June is evident, says UBS
BMY Bristol-Myers
$61.67 /

+1.98 (+3.32%)

07:23 Today Citi
Investors can refocus on Bristol-Myers story after Eliquis win, says Citi
07/28/20 Mizuho
Wait for Bristol-Myers' bb2121 submission making some 'nervous,' says Mizuho
07/28/20
Fly Intel: Top five analyst initiations
07/28/20 Raymond James
Bristol-Myers initiated with an Outperform at Raymond James
SNY Sanofi
$51.41 /

-0.27 (-0.52%)

RHHBY Roche
$0.00 /

+ (+0.00%)

PFE Pfizer
$38.73 /

+0.28 (+0.73%)

NVS Novartis
$83.51 /

+0.07 (+0.08%)

MRK Merck
$81.48 /

-0.13 (-0.16%)

LLY Eli Lilly
$154.75 /

+0.36 (+0.23%)

JNJ Johnson & Johnson
$148.29 /

-0.1 (-0.07%)

GSK GlaxoSmithKline
$41.04 /

-0.17 (-0.41%)

BMY Bristol-Myers
$61.67 /

+1.98 (+3.32%)

AZN AstraZeneca
$56.22 /

+0.3 (+0.54%)

SNY Sanofi
$51.41 /

-0.27 (-0.52%)

RHHBY Roche
$0.00 /

+ (+0.00%)

PFE Pfizer
$38.73 /

+0.28 (+0.73%)

NVS Novartis
$83.51 /

+0.07 (+0.08%)

MRK Merck
$81.48 /

-0.13 (-0.16%)

LLY Eli Lilly
$154.75 /

+0.36 (+0.23%)

JNJ Johnson & Johnson
$148.29 /

-0.1 (-0.07%)

GSK GlaxoSmithKline
$41.04 /

-0.17 (-0.41%)

AZN AstraZeneca
$56.22 /

+0.3 (+0.54%)

SNY Sanofi
$51.41 /

-0.27 (-0.52%)

RHHBY Roche
$0.00 /

+ (+0.00%)

NVS Novartis
$83.51 /

+0.07 (+0.08%)

MRK Merck
$81.48 /

-0.13 (-0.16%)

LLY Eli Lilly
$154.75 /

+0.36 (+0.23%)

JNJ Johnson & Johnson
$148.29 /

-0.1 (-0.07%)

GSK GlaxoSmithKline
$41.04 /

-0.17 (-0.41%)

BMY Bristol-Myers
$61.67 /

+1.98 (+3.32%)

AZN AstraZeneca
$56.22 /

+0.3 (+0.54%)

SNY Sanofi
$51.41 /

-0.27 (-0.52%)

PFE Pfizer
$38.73 /

+0.28 (+0.73%)

NVS Novartis
$83.51 /

+0.07 (+0.08%)

MRK Merck
$81.48 /

-0.13 (-0.16%)

LLY Eli Lilly
$154.75 /

+0.36 (+0.23%)

JNJ Johnson & Johnson
$148.29 /

-0.1 (-0.07%)

GSK GlaxoSmithKline
$41.04 /

-0.17 (-0.41%)

BMY Bristol-Myers
$61.67 /

+1.98 (+3.32%)

AZN AstraZeneca
$56.22 /

+0.3 (+0.54%)

Hot Stocks
Bristol-Myers reports district court upheld Eliquis patents » 07:23
08/06/20
08/06
07:23
08/06/20
07:23
BMY

Bristol-Myers

$59.69 /

+0.26 (+0.44%)

, PFE

Pfizer

$38.45 /

+0.07 (+0.18%)

In August, the…

In August, the Bristol-Myers Squibb-Pfizer Alliance announced the U.S. District Court decision to uphold both the composition of matter patent, US 6,967,208, and formulation patent, US 9,326,945, covering Eliquis, Bristol noted along with its earnings report.

ShowHide Related Items >><<
PFE Pfizer
$38.45 /

+0.07 (+0.18%)

BMY Bristol-Myers
$59.69 /

+0.26 (+0.44%)

BMY Bristol-Myers
$59.69 /

+0.26 (+0.44%)

07/28/20 Mizuho
Wait for Bristol-Myers' bb2121 submission making some 'nervous,' says Mizuho
07/28/20
Fly Intel: Top five analyst initiations
07/28/20 Raymond James
Bristol-Myers initiated with an Outperform at Raymond James
07/22/20 Morgan Stanley
Morgan Stanley sees 'encouraging news' coming in near-term for Bristol-Myers
PFE Pfizer
$38.45 /

+0.07 (+0.18%)

08/03/20 Jefferies
Moderna's Phase 3 data on COVID vaccine could come by October, says Jefferies
07/30/20 BofA
BofA says hard to compare Moderna COVID data to competing preclinical data
07/30/20 Morgan Stanley
Pfizer price target raised to $42 from $36 at Morgan Stanley
07/30/20 Mizuho
Pfizer price target raised to $43 from $38 at Mizuho
PFE Pfizer
$38.45 /

+0.07 (+0.18%)

BMY Bristol-Myers
$59.69 /

+0.26 (+0.44%)

PFE Pfizer
$38.45 /

+0.07 (+0.18%)

BMY Bristol-Myers
$59.69 /

+0.26 (+0.44%)

PFE Pfizer
$38.45 /

+0.07 (+0.18%)

BMY Bristol-Myers
$59.69 /

+0.26 (+0.44%)

PFE Pfizer
$38.45 /

+0.07 (+0.18%)

BMY Bristol-Myers
$59.69 /

+0.26 (+0.44%)

Periodicals
Early Covid vaccine supplies likely to fall short of what is needed, WSJ reports » 06:18
08/06/20
08/06
06:18
08/06/20
06:18
MRNA

Moderna

$75.76 /

-2.72 (-3.47%)

, PFE

Pfizer

$38.45 /

+0.07 (+0.18%)

, NVAX

Novavax

$173.38 /

+16.23 (+10.33%)

, AZN

AstraZeneca

$55.92 /

-0.145 (-0.26%)

Initial supplies of any…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PFE Pfizer
$38.45 /

+0.07 (+0.18%)

NVAX Novavax
$173.38 /

+16.23 (+10.33%)

MRNA Moderna
$75.76 /

-2.72 (-3.47%)

AZN AstraZeneca
$55.92 /

-0.145 (-0.26%)

MRNA Moderna
$75.76 /

-2.72 (-3.47%)

08/05/20 Piper Sandler
Piper reiterates $134 target on Moderna, notes Q2 ended with $3.1B cash
08/03/20 Jefferies
Moderna's Phase 3 data on COVID vaccine could come by October, says Jefferies
07/30/20 BofA
BofA says hard to compare Moderna COVID data to competing preclinical data
07/27/20 Piper Sandler
Piper reiterates $134 Moderna target on start of Phase III vaccine trial
PFE Pfizer
$38.45 /

+0.07 (+0.18%)

07/30/20 Morgan Stanley
Pfizer price target raised to $42 from $36 at Morgan Stanley
07/30/20 Mizuho
Pfizer price target raised to $43 from $38 at Mizuho
NVAX Novavax
$173.38 /

+16.23 (+10.33%)

08/05/20
Fly Intel: Top five analyst downgrades
08/05/20
Fly Intel: Top five analyst upgrades
08/05/20 B. Riley FBR
Novavax price target raised to $257 from $184 at B. Riley FBR
08/05/20 Cantor Fitzgerald
Novavax price target raised to $211 from $148 at Cantor Fitzgerald
AZN AstraZeneca
$55.92 /

-0.145 (-0.26%)

07/31/20 Barclays
Barclays backs Overweight on AstraZeneca after Q2 results
07/29/20 Barclays
AstraZeneca price target raised to 9,300 GBp from 9,200 GBp at Barclays
PFE Pfizer
$38.45 /

+0.07 (+0.18%)

NVAX Novavax
$173.38 /

+16.23 (+10.33%)

MRNA Moderna
$75.76 /

-2.72 (-3.47%)

AZN AstraZeneca
$55.92 /

-0.145 (-0.26%)

  • 19
    May
  • 12
    Feb
PFE Pfizer
$38.45 /

+0.07 (+0.18%)

NVAX Novavax
$173.38 /

+16.23 (+10.33%)

MRNA Moderna
$75.76 /

-2.72 (-3.47%)

AZN AstraZeneca
$55.92 /

-0.145 (-0.26%)

NVAX Novavax
$173.38 /

+16.23 (+10.33%)

MRNA Moderna
$75.76 /

-2.72 (-3.47%)

AZN AstraZeneca
$55.92 /

-0.145 (-0.26%)

PFE Pfizer
$38.45 /

+0.07 (+0.18%)

NVAX Novavax
$173.38 /

+16.23 (+10.33%)

MRNA Moderna
$75.76 /

-2.72 (-3.47%)

AZN AstraZeneca
$55.92 /

-0.145 (-0.26%)

Yesterday
On The Fly
Fly Intel: Wall Street's top stories for Wednesday » 17:41
08/05/20
08/05
17:41
08/05/20
17:41
DIS

Disney

$127.64 /

+10.185 (+8.67%)

, CVS

CVS Health

$64.44 /

-0.55 (-0.85%)

, NVAX

Novavax

$173.38 /

+16.23 (+10.33%)

, JNJ

Johnson & Johnson

$148.39 /

+1.19 (+0.81%)

, PFE

Pfizer

$38.45 /

+0.07 (+0.18%)

, BNTX

BioNTech

$81.28 /

-1.89 (-2.27%)

, MRNA

Moderna

$75.76 /

-2.72 (-3.47%)

, TDOC

Teladoc

$202.21 /

-46.9 (-18.83%)

, LVGO

Livongo Health

$128.16 /

-16.32 (-11.30%)

, XOM

Exxon Mobil

$43.84 /

+0.36 (+0.83%)

, CI

Cigna

$175.07 /

+1.53 (+0.88%)

, FLGT

Fulgent Genetics

$35.97 /

+6.29 (+21.19%)

, ENLC

EnLink Midstream

$2.99 /

+0.455 (+17.95%)

, LPSN

LivePerson

$56.16 /

+9.91 (+21.43%)

, AIZ

Assurant

$122.40 /

+15.32 (+14.31%)

, EVER

EverQuote

$41.61 /

-12.64 (-23.30%)

, VAPO

Vapotherm

$32.87 /

-20.59 (-38.51%)

, NEWR

New Relic

$55.85 /

-17.655 (-24.02%)

, CDLX

Cardlytics

$66.08 /

-6.6 (-9.08%)

The S&P had its fourth…

Open Full Text

ShowHide Related Items >><<
XOM Exxon Mobil
$43.84 /

+0.36 (+0.83%)

VAPO Vapotherm
$32.87 /

-20.59 (-38.51%)

TDOC Teladoc
$202.21 /

-46.9 (-18.83%)

PFE Pfizer
$38.45 /

+0.07 (+0.18%)

NVAX Novavax
$173.38 /

+16.23 (+10.33%)

NEWR New Relic
$55.85 /

-17.655 (-24.02%)

MRNA Moderna
$75.76 /

-2.72 (-3.47%)

LVGO Livongo Health
$128.16 /

-16.32 (-11.30%)

LPSN LivePerson
$56.16 /

+9.91 (+21.43%)

JNJ Johnson & Johnson
$148.39 /

+1.19 (+0.81%)

FLGT Fulgent Genetics
$35.97 /

+6.29 (+21.19%)

EVER EverQuote
$41.61 /

-12.64 (-23.30%)

ENLC EnLink Midstream
$2.99 /

+0.455 (+17.95%)

DIS Disney
$127.64 /

+10.185 (+8.67%)

CVS CVS Health
$64.44 /

-0.55 (-0.85%)

CI Cigna
$175.07 /

+1.53 (+0.88%)

CDLX Cardlytics
$66.08 /

-6.6 (-9.08%)

BNTX BioNTech
$81.28 /

-1.89 (-2.27%)

AIZ Assurant
$122.40 /

+15.32 (+14.31%)

DIS Disney
$127.64 /

+10.185 (+8.67%)

08/05/20
Fly Intel: Top five analyst upgrades
08/05/20 JPMorgan
Disney remains top pick in media post Q3 results at JPMorgan
08/05/20 Needham
Needham says still 'too early' to buy Disney, keeps Hold rating after earnings
08/05/20 BMO Capital
Disney price target raised to $150 from $140 at BMO Capital
CVS CVS Health
$64.44 /

-0.55 (-0.85%)

07:55 Today Deutsche Bank
CVS Health price target lowered to $104 from $109 at Deutsche Bank
07/29/20 RBC Capital
Livongo Health ending re-seller relationship with CVS Health, says RBC Capital
07/01/20 SVB Leerink
CVS Health reinstated with a Market Perform at SVB Leerink
06/01/20 Stephens
Molina Healthcare price target raised to $215 from $202 at Stephens
NVAX Novavax
$173.38 /

+16.23 (+10.33%)

06:59 Today Barclays
Moderna COVID vaccine still has 'best-in-class potential,' says Barclays
06:38 Today H.C. Wainwright
Novavax price target raised to $290 from $132 at H.C. Wainwright
08/05/20
Fly Intel: Top five analyst downgrades
JNJ Johnson & Johnson
$148.39 /

+1.19 (+0.81%)

07/30/20 BofA
BofA says hard to compare Moderna COVID data to competing preclinical data
07/29/20 Laidlaw
Curis initiated with a Buy at Laidlaw
07/17/20 Goldman Sachs
J&J valuation discount to S&P 500 'too wide,' says Goldman Sachs
07/17/20 Citi
Johnson & Johnson price target raised to $170 from $165 at Citi
PFE Pfizer
$38.45 /

+0.07 (+0.18%)

08/03/20 Jefferies
Moderna's Phase 3 data on COVID vaccine could come by October, says Jefferies
07/30/20 Morgan Stanley
Pfizer price target raised to $42 from $36 at Morgan Stanley
07/30/20 Mizuho
Pfizer price target raised to $43 from $38 at Mizuho
BNTX BioNTech
$81.28 /

-1.89 (-2.27%)

07/21/20
Fly Intel: Top five analyst upgrades
MRNA Moderna
$75.76 /

-2.72 (-3.47%)

08/05/20 Piper Sandler
Piper reiterates $134 target on Moderna, notes Q2 ended with $3.1B cash
TDOC Teladoc
$202.21 /

-46.9 (-18.83%)

07:41 Today Deutsche Bank
Teladoc price target lowered to $225 from $238 at Deutsche Bank
07:19 Today Needham
Livongo Health downgraded to Hold from Buy at Needham
07:11 Today Truist
Teladoc upgraded to Buy from Hold at Truist
06:13 Today Truist
Teladoc upgraded to Buy from Hold at Truist
LVGO Livongo Health
$128.16 /

-16.32 (-11.30%)

06:11 Today Needham
Livongo Health downgraded to Hold from Buy at Needham
08/05/20 Stifel
Stifel views Teledoc, Livongo as largely complementary businesses
XOM Exxon Mobil
$43.84 /

+0.36 (+0.83%)

07/23/20 Truist
SunTrust starts Exxon with Hold rating, $41 price target
07/23/20 Truist
Exxon Mobil initiated with a Hold at SunTrust
06/09/20 Standpoint Research
Exxon Mobil downgraded to Hold from Buy at Standpoint Research
06/09/20 JPMorgan
Exxon Mobil price target raised to $51 from $44 at JPMorgan
CI Cigna
$175.07 /

+1.53 (+0.88%)

06:37 Today RBC Capital
Ontrak price target raised to $50 from $35 at RBC Capital
07/01/20 SVB Leerink
Cigna reinstated with a Market Perform at SVB Leerink
06/29/20 SVB Leerink
Inspire Medical price target raised to $110 from $85 at SVB Leerink
06/05/20 BMO Capital
Cigna price target raised to $242 from $215 at BMO Capital
FLGT Fulgent Genetics
$35.97 /

+6.29 (+21.19%)

08/05/20 Piper Sandler
Fulgent Genetics price target raised to $68 from $31 at Piper Sandler
07/27/20 Piper Sandler
Fulgent Genetics price target raised to $31 from $21 at Piper Sandler
06/17/20 Piper Sandler
Fulgent Genetics price target raised to $21 from $18 at Piper Sandler
05/29/20 BTIG
Fulgent Genetics initiated with a Buy at BTIG
ENLC EnLink Midstream
$2.99 /

+0.455 (+17.95%)

05/06/20 Mizuho
EnLink Midstream price target lowered to $2.50 from $7 at Mizuho
04/02/20 Credit Suisse
EnLink Midstream downgraded to Underperform from Neutral at Credit Suisse
03/24/20 Barclays
EnLink Midstream downgraded to Underweight from Equal Weight at Barclays
03/12/20 Raymond James
EnLink Midstream downgraded to Market Perform from Outperform at Raymond James
LPSN LivePerson
$56.16 /

+9.91 (+21.43%)

08/05/20 B. Riley FBR
LivePerson price target raised to $63 from $49 at B. Riley FBR
08/05/20 Barclays
LivePerson price target raised to $64 from $49 at Barclays
08/05/20 Craig-Hallum
LivePerson price target raised to $60 from $34 at Craig-Hallum
08/05/20 Roth Capital
LivePerson price target raised to $75 from $53 at Roth Capital
AIZ Assurant
$122.40 /

+15.32 (+14.31%)

10/03/19 Truist
Assurant price target raised to $145 from $140 at SunTrust
EVER EverQuote
$41.61 /

-12.64 (-23.30%)

07/14/20 BofA
EverQuote downgraded to Underperform from Neutral at BofA
07/14/20 BofA
EverQuote downgraded to Underperform from Neutral at BofA
06/02/20 Oppenheimer
EverQuote price target raised to $65 from $50 at Oppenheimer
05/27/20 Canaccord
EverQuote price target raised to $60 from $50 at Canaccord
VAPO Vapotherm
$32.87 /

-20.59 (-38.51%)

07/13/20 BTIG
Vapotherm price target raised to $53 from $32 at BTIG
06/05/20 Canaccord
Vapotherm price target raised to $34 from $30 at Canaccord
05/06/20 Canaccord
Vapotherm price target raised to $30 from $20 at Canaccord
04/14/20 Canaccord
Vapotherm price target raised to $20 from $14 at Canaccord
NEWR New Relic
$55.85 /

-17.655 (-24.02%)

08/05/20 UBS
New Relic sales turnaround taking longer than expected, says UBS
08/05/20 JPMorgan
New Relic downgraded to Neutral on strategy change at JPMorgan
08/05/20 JPMorgan
New Relic downgraded to Neutral from Overweight at JPMorgan
08/04/20 BMO Capital
New Relic price target raised to $78 from $70 at BMO Capital
CDLX Cardlytics
$66.08 /

-6.6 (-9.08%)

08/05/20 Craig-Hallum
Cardlytics price target raised to $70 from $50 at Craig-Hallum
07/09/20 Truist
Cardlytics price target raised to $75 from $55 at SunTrust
05/12/20 Craig-Hallum
Cardlytics price target lowered to $50 from $70 at Craig-Hallum
05/12/20 Truist
Cardlytics price target raised to $55 from $50 at SunTrust
XOM Exxon Mobil
$43.84 /

+0.36 (+0.83%)

VAPO Vapotherm
$32.87 /

-20.59 (-38.51%)

TDOC Teladoc
$202.21 /

-46.9 (-18.83%)

PFE Pfizer
$38.45 /

+0.07 (+0.18%)

NVAX Novavax
$173.38 /

+16.23 (+10.33%)

NEWR New Relic
$55.85 /

-17.655 (-24.02%)

MRNA Moderna
$75.76 /

-2.72 (-3.47%)

LVGO Livongo Health
$128.16 /

-16.32 (-11.30%)

LPSN LivePerson
$56.16 /

+9.91 (+21.43%)

JNJ Johnson & Johnson
$148.39 /

+1.19 (+0.81%)

FLGT Fulgent Genetics
$35.97 /

+6.29 (+21.19%)

EVER EverQuote
$41.61 /

-12.64 (-23.30%)

ENLC EnLink Midstream
$2.99 /

+0.455 (+17.95%)

DIS Disney
$127.64 /

+10.185 (+8.67%)

CVS CVS Health
$64.44 /

-0.55 (-0.85%)

CI Cigna
$175.07 /

+1.53 (+0.88%)

CDLX Cardlytics
$66.08 /

-6.6 (-9.08%)

BNTX BioNTech
$81.28 /

-1.89 (-2.27%)

AIZ Assurant
$122.40 /

+15.32 (+14.31%)

  • 23
    Jul
  • 19
    May
  • 07
    May
  • 12
    Feb
  • 06
    Feb
  • 12
    Dec
  • 14
    Nov
  • 10
    Oct
  • 11
    Sep
XOM Exxon Mobil
$43.84 /

+0.36 (+0.83%)

TDOC Teladoc
$202.21 /

-46.9 (-18.83%)

PFE Pfizer
$38.45 /

+0.07 (+0.18%)

NVAX Novavax
$173.38 /

+16.23 (+10.33%)

MRNA Moderna
$75.76 /

-2.72 (-3.47%)

LPSN LivePerson
$56.16 /

+9.91 (+21.43%)

JNJ Johnson & Johnson
$148.39 /

+1.19 (+0.81%)

DIS Disney
$127.64 /

+10.185 (+8.67%)

CVS CVS Health
$64.44 /

-0.55 (-0.85%)

CI Cigna
$175.07 /

+1.53 (+0.88%)

BNTX BioNTech
$81.28 /

-1.89 (-2.27%)

XOM Exxon Mobil
$43.84 /

+0.36 (+0.83%)

VAPO Vapotherm
$32.87 /

-20.59 (-38.51%)

TDOC Teladoc
$202.21 /

-46.9 (-18.83%)

NVAX Novavax
$173.38 /

+16.23 (+10.33%)

NEWR New Relic
$55.85 /

-17.655 (-24.02%)

LVGO Livongo Health
$128.16 /

-16.32 (-11.30%)

LPSN LivePerson
$56.16 /

+9.91 (+21.43%)

JNJ Johnson & Johnson
$148.39 /

+1.19 (+0.81%)

FLGT Fulgent Genetics
$35.97 /

+6.29 (+21.19%)

ENLC EnLink Midstream
$2.99 /

+0.455 (+17.95%)

DIS Disney
$127.64 /

+10.185 (+8.67%)

CVS CVS Health
$64.44 /

-0.55 (-0.85%)

CI Cigna
$175.07 /

+1.53 (+0.88%)

CDLX Cardlytics
$66.08 /

-6.6 (-9.08%)

BNTX BioNTech
$81.28 /

-1.89 (-2.27%)

XOM Exxon Mobil
$43.84 /

+0.36 (+0.83%)

VAPO Vapotherm
$32.87 /

-20.59 (-38.51%)

TDOC Teladoc
$202.21 /

-46.9 (-18.83%)

PFE Pfizer
$38.45 /

+0.07 (+0.18%)

NVAX Novavax
$173.38 /

+16.23 (+10.33%)

MRNA Moderna
$75.76 /

-2.72 (-3.47%)

LVGO Livongo Health
$128.16 /

-16.32 (-11.30%)

LPSN LivePerson
$56.16 /

+9.91 (+21.43%)

JNJ Johnson & Johnson
$148.39 /

+1.19 (+0.81%)

DIS Disney
$127.64 /

+10.185 (+8.67%)

CVS CVS Health
$64.44 /

-0.55 (-0.85%)

CI Cigna
$175.07 /

+1.53 (+0.88%)

CDLX Cardlytics
$66.08 /

-6.6 (-9.08%)

BNTX BioNTech
$81.28 /

-1.89 (-2.27%)

On The Fly
Fly Intel: Wall Street's top stories at midday » 12:48
08/05/20
08/05
12:48
08/05/20
12:48
DIS

Disney

$128.20 /

+10.75 (+9.15%)

, NVAX

Novavax

$174.54 /

+17.39 (+11.07%)

, JNJ

Johnson & Johnson

$147.96 /

+0.76 (+0.52%)

, PFE

Pfizer

$38.33 /

-0.05 (-0.13%)

, MRNA

Moderna

$75.60 /

-2.88 (-3.67%)

, LVGO

Livongo Health

$135.39 /

-9.09 (-6.29%)

, CVS

CVS Health

$64.21 /

-0.78 (-1.20%)

, FLGT

Fulgent Genetics

$36.85 /

+7.17 (+24.16%)

, ENLC

EnLink Midstream

$3.11 /

+0.57 (+22.49%)

, LPSN

LivePerson

$56.54 /

+10.29 (+22.25%)

, AIZ

Assurant

$122.92 /

+15.84 (+14.79%)

, EVER

EverQuote

$45.02 /

-9.235 (-17.02%)

, VAPO

Vapotherm

$32.62 /

-20.84 (-38.98%)

, NEWR

New Relic

$55.10 /

-18.405 (-25.04%)

, CDLX

Cardlytics

$65.67 /

-7.01 (-9.65%)

, BNTX

BioNTech

$81.21 /

-1.96 (-2.36%)

, TDOC

Teladoc

$214.70 /

-34.41 (-13.81%)

The S&P is heading…

Open Full Text

ShowHide Related Items >><<
VAPO Vapotherm
$32.62 /

-20.84 (-38.98%)

TDOC Teladoc
$214.70 /

-34.41 (-13.81%)

PFE Pfizer
$38.33 /

-0.05 (-0.13%)

NVAX Novavax
$174.54 /

+17.39 (+11.07%)

NEWR New Relic
$55.10 /

-18.405 (-25.04%)

MRNA Moderna
$75.60 /

-2.88 (-3.67%)

LVGO Livongo Health
$135.39 /

-9.09 (-6.29%)

LPSN LivePerson
$56.54 /

+10.29 (+22.25%)

JNJ Johnson & Johnson
$147.96 /

+0.76 (+0.52%)

FLGT Fulgent Genetics
$36.85 /

+7.17 (+24.16%)

EVER EverQuote
$45.02 /

-9.235 (-17.02%)

ENLC EnLink Midstream
$3.11 /

+0.57 (+22.49%)

DIS Disney
$128.20 /

+10.75 (+9.15%)

CVS CVS Health
$64.21 /

-0.78 (-1.20%)

CDLX Cardlytics
$65.67 /

-7.01 (-9.65%)

BNTX BioNTech
$81.21 /

-1.96 (-2.36%)

AIZ Assurant
$122.92 /

+15.84 (+14.79%)

DIS Disney
$128.20 /

+10.75 (+9.15%)

08/05/20
Fly Intel: Top five analyst upgrades
08/05/20 JPMorgan
Disney remains top pick in media post Q3 results at JPMorgan
08/05/20 Needham
Needham says still 'too early' to buy Disney, keeps Hold rating after earnings
08/05/20 BMO Capital
Disney price target raised to $150 from $140 at BMO Capital
NVAX Novavax
$174.54 /

+17.39 (+11.07%)

08/05/20
Fly Intel: Top five analyst downgrades
08/05/20 B. Riley FBR
Novavax price target raised to $257 from $184 at B. Riley FBR
08/05/20 Cantor Fitzgerald
Novavax price target raised to $211 from $148 at Cantor Fitzgerald
JNJ Johnson & Johnson
$147.96 /

+0.76 (+0.52%)

07/30/20 BofA
BofA says hard to compare Moderna COVID data to competing preclinical data
07/29/20 Laidlaw
Curis initiated with a Buy at Laidlaw
07/17/20 Goldman Sachs
J&J valuation discount to S&P 500 'too wide,' says Goldman Sachs
07/17/20 Citi
Johnson & Johnson price target raised to $170 from $165 at Citi
PFE Pfizer
$38.33 /

-0.05 (-0.13%)

08/03/20 Jefferies
Moderna's Phase 3 data on COVID vaccine could come by October, says Jefferies
07/30/20 Morgan Stanley
Pfizer price target raised to $42 from $36 at Morgan Stanley
07/30/20 Mizuho
Pfizer price target raised to $43 from $38 at Mizuho
MRNA Moderna
$75.60 /

-2.88 (-3.67%)

08/05/20 Piper Sandler
Piper reiterates $134 target on Moderna, notes Q2 ended with $3.1B cash
07/27/20 Piper Sandler
Piper reiterates $134 Moderna target on start of Phase III vaccine trial
LVGO Livongo Health
$135.39 /

-9.09 (-6.29%)

08/05/20 JPMorgan
JPMorgan views combination with Livongo as positive for Teladoc
08/05/20 Piper Sandler
Teladoc 'thinking bigger' with Livongo Health takeover deal, says Piper Sandler
07/29/20 RBC Capital
Livongo Health ending re-seller relationship with CVS Health, says RBC Capital
07/15/20
Fly Intel: Top five analyst initiations
CVS CVS Health
$64.21 /

-0.78 (-1.20%)

07/01/20 SVB Leerink
CVS Health reinstated with a Market Perform at SVB Leerink
06/01/20 Stephens
Molina Healthcare price target raised to $215 from $202 at Stephens
05/14/20
Fly Intel: Top five analyst upgrades
FLGT Fulgent Genetics
$36.85 /

+7.17 (+24.16%)

08/05/20 Piper Sandler
Fulgent Genetics price target raised to $68 from $31 at Piper Sandler
07/27/20 Piper Sandler
Fulgent Genetics price target raised to $31 from $21 at Piper Sandler
06/17/20 Piper Sandler
Fulgent Genetics price target raised to $21 from $18 at Piper Sandler
05/29/20 BTIG
Fulgent Genetics initiated with a Buy at BTIG
ENLC EnLink Midstream
$3.11 /

+0.57 (+22.49%)

05/06/20 Mizuho
EnLink Midstream price target lowered to $2.50 from $7 at Mizuho
04/02/20 Credit Suisse
EnLink Midstream downgraded to Underperform from Neutral at Credit Suisse
03/24/20 Barclays
EnLink Midstream downgraded to Underweight from Equal Weight at Barclays
03/12/20 Raymond James
EnLink Midstream downgraded to Market Perform from Outperform at Raymond James
LPSN LivePerson
$56.54 /

+10.29 (+22.25%)

08/05/20 B. Riley FBR
LivePerson price target raised to $63 from $49 at B. Riley FBR
08/05/20 Barclays
LivePerson price target raised to $64 from $49 at Barclays
08/05/20 Craig-Hallum
LivePerson price target raised to $60 from $34 at Craig-Hallum
08/05/20 Roth Capital
LivePerson price target raised to $75 from $53 at Roth Capital
AIZ Assurant
$122.92 /

+15.84 (+14.79%)

10/03/19 Truist
Assurant price target raised to $145 from $140 at SunTrust
EVER EverQuote
$45.02 /

-9.235 (-17.02%)

07/14/20 BofA
EverQuote downgraded to Underperform from Neutral at BofA
07/14/20 BofA
EverQuote downgraded to Underperform from Neutral at BofA
06/02/20 Oppenheimer
EverQuote price target raised to $65 from $50 at Oppenheimer
05/27/20 Canaccord
EverQuote price target raised to $60 from $50 at Canaccord
VAPO Vapotherm
$32.62 /

-20.84 (-38.98%)

07/13/20 BTIG
Vapotherm price target raised to $53 from $32 at BTIG
06/05/20 Canaccord
Vapotherm price target raised to $34 from $30 at Canaccord
05/06/20 Canaccord
Vapotherm price target raised to $30 from $20 at Canaccord
04/14/20 Canaccord
Vapotherm price target raised to $20 from $14 at Canaccord
NEWR New Relic
$55.10 /

-18.405 (-25.04%)

08/05/20 UBS
New Relic sales turnaround taking longer than expected, says UBS
08/05/20 JPMorgan
New Relic downgraded to Neutral on strategy change at JPMorgan
08/05/20 JPMorgan
New Relic downgraded to Neutral from Overweight at JPMorgan
08/04/20 BMO Capital
New Relic price target raised to $78 from $70 at BMO Capital
CDLX Cardlytics
$65.67 /

-7.01 (-9.65%)

08/05/20 Craig-Hallum
Cardlytics price target raised to $70 from $50 at Craig-Hallum
07/09/20 Truist
Cardlytics price target raised to $75 from $55 at SunTrust
05/12/20 Craig-Hallum
Cardlytics price target lowered to $50 from $70 at Craig-Hallum
05/12/20 Truist
Cardlytics price target raised to $55 from $50 at SunTrust
BNTX BioNTech
$81.21 /

-1.96 (-2.36%)

07/21/20
Fly Intel: Top five analyst upgrades
TDOC Teladoc
$214.70 /

-34.41 (-13.81%)

07/30/20 Wells Fargo
Teladoc price target raised to $175 from $135 at Wells Fargo
07/30/20 Canaccord
Teladoc price target raised to $255 from $195 at Canaccord
VAPO Vapotherm
$32.62 /

-20.84 (-38.98%)

TDOC Teladoc
$214.70 /

-34.41 (-13.81%)

PFE Pfizer
$38.33 /

-0.05 (-0.13%)

NVAX Novavax
$174.54 /

+17.39 (+11.07%)

NEWR New Relic
$55.10 /

-18.405 (-25.04%)

MRNA Moderna
$75.60 /

-2.88 (-3.67%)

LVGO Livongo Health
$135.39 /

-9.09 (-6.29%)

LPSN LivePerson
$56.54 /

+10.29 (+22.25%)

JNJ Johnson & Johnson
$147.96 /

+0.76 (+0.52%)

FLGT Fulgent Genetics
$36.85 /

+7.17 (+24.16%)

EVER EverQuote
$45.02 /

-9.235 (-17.02%)

ENLC EnLink Midstream
$3.11 /

+0.57 (+22.49%)

DIS Disney
$128.20 /

+10.75 (+9.15%)

CVS CVS Health
$64.21 /

-0.78 (-1.20%)

CDLX Cardlytics
$65.67 /

-7.01 (-9.65%)

BNTX BioNTech
$81.21 /

-1.96 (-2.36%)

AIZ Assurant
$122.92 /

+15.84 (+14.79%)

  • 23
    Jul
  • 19
    May
  • 07
    May
  • 12
    Feb
  • 06
    Feb
  • 12
    Dec
  • 14
    Nov
  • 10
    Oct
  • 11
    Sep
TDOC Teladoc
$214.70 /

-34.41 (-13.81%)

PFE Pfizer
$38.33 /

-0.05 (-0.13%)

NVAX Novavax
$174.54 /

+17.39 (+11.07%)

MRNA Moderna
$75.60 /

-2.88 (-3.67%)

LVGO Livongo Health
$135.39 /

-9.09 (-6.29%)

LPSN LivePerson
$56.54 /

+10.29 (+22.25%)

JNJ Johnson & Johnson
$147.96 /

+0.76 (+0.52%)

DIS Disney
$128.20 /

+10.75 (+9.15%)

CVS CVS Health
$64.21 /

-0.78 (-1.20%)

BNTX BioNTech
$81.21 /

-1.96 (-2.36%)

VAPO Vapotherm
$32.62 /

-20.84 (-38.98%)

TDOC Teladoc
$214.70 /

-34.41 (-13.81%)

PFE Pfizer
$38.33 /

-0.05 (-0.13%)

NVAX Novavax
$174.54 /

+17.39 (+11.07%)

NEWR New Relic
$55.10 /

-18.405 (-25.04%)

MRNA Moderna
$75.60 /

-2.88 (-3.67%)

LVGO Livongo Health
$135.39 /

-9.09 (-6.29%)

LPSN LivePerson
$56.54 /

+10.29 (+22.25%)

JNJ Johnson & Johnson
$147.96 /

+0.76 (+0.52%)

FLGT Fulgent Genetics
$36.85 /

+7.17 (+24.16%)

ENLC EnLink Midstream
$3.11 /

+0.57 (+22.49%)

DIS Disney
$128.20 /

+10.75 (+9.15%)

CVS CVS Health
$64.21 /

-0.78 (-1.20%)

CDLX Cardlytics
$65.67 /

-7.01 (-9.65%)

BNTX BioNTech
$81.21 /

-1.96 (-2.36%)

VAPO Vapotherm
$32.62 /

-20.84 (-38.98%)

TDOC Teladoc
$214.70 /

-34.41 (-13.81%)

PFE Pfizer
$38.33 /

-0.05 (-0.13%)

NVAX Novavax
$174.54 /

+17.39 (+11.07%)

MRNA Moderna
$75.60 /

-2.88 (-3.67%)

LVGO Livongo Health
$135.39 /

-9.09 (-6.29%)

LPSN LivePerson
$56.54 /

+10.29 (+22.25%)

JNJ Johnson & Johnson
$147.96 /

+0.76 (+0.52%)

DIS Disney
$128.20 /

+10.75 (+9.15%)

CVS CVS Health
$64.21 /

-0.78 (-1.20%)

CDLX Cardlytics
$65.67 /

-7.01 (-9.65%)

BNTX BioNTech
$81.21 /

-1.96 (-2.36%)

On The Fly
Street Fight: JPMorgan says buy Novavax, Ladenburg says sell after vaccine data » 11:08
08/05/20
08/05
11:08
08/05/20
11:08
NVAX

Novavax

$170.87 /

+13.72 (+8.73%)

, MRNA

Moderna

$74.31 /

-4.17 (-5.31%)

, JNJ

Johnson & Johnson

$148.12 /

+0.92 (+0.63%)

, PFE

Pfizer

$38.24 /

-0.14 (-0.36%)

, BNTX

BioNTech

$80.00 /

-3.17 (-3.81%)

Shares of Novavax (NVAX)…

Open Full Text

ShowHide Related Items >><<
PFE Pfizer
$38.24 /

-0.14 (-0.36%)

NVAX Novavax
$170.87 /

+13.72 (+8.73%)

MRNA Moderna
$74.31 /

-4.17 (-5.31%)

JNJ Johnson & Johnson
$148.12 /

+0.92 (+0.63%)

BNTX BioNTech
$80.00 /

-3.17 (-3.81%)

NVAX Novavax
$170.87 /

+13.72 (+8.73%)

08/05/20
Fly Intel: Top five analyst downgrades
08/05/20
Fly Intel: Top five analyst upgrades
08/05/20 B. Riley FBR
Novavax price target raised to $257 from $184 at B. Riley FBR
08/05/20 Cantor Fitzgerald
Novavax price target raised to $211 from $148 at Cantor Fitzgerald
MRNA Moderna
$74.31 /

-4.17 (-5.31%)

08/05/20 Piper Sandler
Piper reiterates $134 target on Moderna, notes Q2 ended with $3.1B cash
08/03/20 Jefferies
Moderna's Phase 3 data on COVID vaccine could come by October, says Jefferies
07/30/20 BofA
BofA says hard to compare Moderna COVID data to competing preclinical data
07/27/20 Piper Sandler
Piper reiterates $134 Moderna target on start of Phase III vaccine trial
JNJ Johnson & Johnson
$148.12 /

+0.92 (+0.63%)

07/29/20 Laidlaw
Curis initiated with a Buy at Laidlaw
07/17/20 Goldman Sachs
J&J valuation discount to S&P 500 'too wide,' says Goldman Sachs
07/17/20 Citi
Johnson & Johnson price target raised to $170 from $165 at Citi
PFE Pfizer
$38.24 /

-0.14 (-0.36%)

07/30/20 Morgan Stanley
Pfizer price target raised to $42 from $36 at Morgan Stanley
07/30/20 Mizuho
Pfizer price target raised to $43 from $38 at Mizuho
BNTX BioNTech
$80.00 /

-3.17 (-3.81%)

07/21/20
Fly Intel: Top five analyst upgrades
PFE Pfizer
$38.24 /

-0.14 (-0.36%)

NVAX Novavax
$170.87 /

+13.72 (+8.73%)

MRNA Moderna
$74.31 /

-4.17 (-5.31%)

JNJ Johnson & Johnson
$148.12 /

+0.92 (+0.63%)

BNTX BioNTech
$80.00 /

-3.17 (-3.81%)

  • 23
    Jul
  • 19
    May
  • 12
    Feb
  • 06
    Feb
  • 10
    Oct
PFE Pfizer
$38.24 /

-0.14 (-0.36%)

NVAX Novavax
$170.87 /

+13.72 (+8.73%)

MRNA Moderna
$74.31 /

-4.17 (-5.31%)

JNJ Johnson & Johnson
$148.12 /

+0.92 (+0.63%)

BNTX BioNTech
$80.00 /

-3.17 (-3.81%)

PFE Pfizer
$38.24 /

-0.14 (-0.36%)

NVAX Novavax
$170.87 /

+13.72 (+8.73%)

MRNA Moderna
$74.31 /

-4.17 (-5.31%)

JNJ Johnson & Johnson
$148.12 /

+0.92 (+0.63%)

BNTX BioNTech
$80.00 /

-3.17 (-3.81%)

PFE Pfizer
$38.24 /

-0.14 (-0.36%)

NVAX Novavax
$170.87 /

+13.72 (+8.73%)

MRNA Moderna
$74.31 /

-4.17 (-5.31%)

JNJ Johnson & Johnson
$148.12 /

+0.92 (+0.63%)

BNTX BioNTech
$80.00 /

-3.17 (-3.81%)

Periodicals
Canada in agreement with Pfizer, Moderna for COVID vaccines, BNN Bloomberg says » 10:18
08/05/20
08/05
10:18
08/05/20
10:18
MRNA

Moderna

$74.15 /

-4.33 (-5.52%)

, PFE

Pfizer

$38.29 /

-0.09 (-0.23%)

BNN Bloomberg reported…

BNN Bloomberg reported via Twitter that, "#BREAKING CANADA IN AGREEMENT WITH PFIZER AND MODERNA FOR COVID VACCINES." Both Pfizer (PFE) and Moderna (MRNA) are currently developing COVID-19 vaccines. Reference Link

ShowHide Related Items >><<
PFE Pfizer
$38.29 /

-0.09 (-0.23%)

MRNA Moderna
$74.15 /

-4.33 (-5.52%)

MRNA Moderna
$74.15 /

-4.33 (-5.52%)

08/03/20 Jefferies
Moderna's Phase 3 data on COVID vaccine could come by October, says Jefferies
07/30/20 BofA
BofA says hard to compare Moderna COVID data to competing preclinical data
07/27/20 Piper Sandler
Piper reiterates $134 Moderna target on start of Phase III vaccine trial
07/27/20 BMO Capital
Moderna price target lowered to $94 from $112 at BMO Capital
PFE Pfizer
$38.29 /

-0.09 (-0.23%)

07/30/20 Morgan Stanley
Pfizer price target raised to $42 from $36 at Morgan Stanley
07/30/20 Mizuho
Pfizer price target raised to $43 from $38 at Mizuho
PFE Pfizer
$38.29 /

-0.09 (-0.23%)

MRNA Moderna
$74.15 /

-4.33 (-5.52%)

  • 19
    May
  • 12
    Feb
PFE Pfizer
$38.29 /

-0.09 (-0.23%)

MRNA Moderna
$74.15 /

-4.33 (-5.52%)

PFE Pfizer
$38.29 /

-0.09 (-0.23%)

MRNA Moderna
$74.15 /

-4.33 (-5.52%)

PFE Pfizer
$38.29 /

-0.09 (-0.23%)

MRNA Moderna
$74.15 /

-4.33 (-5.52%)

Hot Stocks
Pfizer, BioNTech to supply Canada with BNT162 mRNA-based vaccine candidate » 08:04
08/05/20
08/05
08:04
08/05/20
08:04
PFE

Pfizer

$38.38 /

+0.025 (+0.07%)

, BNTX

BioNTech

$83.17 /

-2.23 (-2.61%)

Pfizer Canada (PFE) and…

Pfizer Canada (PFE) and BioNTech SE (BNTX) announced an agreement with the Government of Canada to supply their BNT162 mRNA-based vaccine candidate against SARS-CoV-2, subject to clinical success and Health Canada approval. Financial details of the agreement were not disclosed, but the terms were based on the timing of delivery and the volume of doses. As requested by the Government of Canada, deliveries of the vaccine candidate are planned for over the course of 2021. The BNT162 program is based on BioNTech's proprietary mRNA technology and supported by Pfizer's global vaccine development and manufacturing capabilities. The vaccine development program is evaluating at least four experimental vaccine candidates, each of which represents a unique combination of messenger RNA format and target antigen. The BNT162 vaccine candidates are undergoing clinical studies and are not currently approved for distribution anywhere in the world. Both collaborators are committed to developing these novel vaccines with pre-clinical and clinical data at the forefront of all their decision-making. Recently, two of the companies' four investigational vaccine candidates - BNT162b1 and BNT162b2 - received Fast Track designation from the U.S. Food and Drug Administration. This designation was granted based on preliminary data from Phase 1/2 studies that are currently ongoing in the United States and Germany as well as animal immunogenicity studies. On July 27, Pfizer and BioNTech announced that following extensive review of preclinical and clinical data from Phase 1/2 clinical trials, and in consultation with the U.S. FDA's Center for Biologics Evaluation and Research and other global regulators, the companies selected the BNT162b2 vaccine candidate to move forward into a Phase 2/3 study. BNT162b2 encodes an optimized SARS-CoV-2 full length spike glycoprotein, which is the target of virus neutralizing antibodies. In the late-stage trial, the companies will study a 30 microgram dose level in a 2-dose-regimen among up to 30,000 participants aged 18 to 85 years. It is expected to include approximately 120 sites globally including in regions with significant expected SARS-CoV-2 transmission. BNT162b2 has received Fast Track designation from the U.S. FDA. Assuming clinical success, Pfizer and BioNTech are on track to seek regulatory review for BNT162b2 as early as October 2020 and, if regulatory authorization or approval is obtained, plan to supply up to 100 million doses worldwide by the end of 2020 and approximately 1.3 billion doses by the end of 2021. In addition to engagements with governments, Pfizer and BioNTech have provided an expression of interest for possible supply to the COVAX Facility, a mechanism established by Gavi, the Vaccine Alliance, the Coalition for Epidemic Preparedness Innovations and World Health Organization that aims to provide governments, including those in the emerging markets, with early access to a large portfolio of COVID-19 candidate vaccines using a range of technology platforms, produced by multiple manufacturers across the world.

ShowHide Related Items >><<
PFE Pfizer
$38.38 /

+0.025 (+0.07%)

BNTX BioNTech
$83.17 /

-2.23 (-2.61%)

PFE Pfizer
$38.38 /

+0.025 (+0.07%)

08/03/20 Jefferies
Moderna's Phase 3 data on COVID vaccine could come by October, says Jefferies
07/30/20 BofA
BofA says hard to compare Moderna COVID data to competing preclinical data
07/30/20 Morgan Stanley
Pfizer price target raised to $42 from $36 at Morgan Stanley
07/30/20 Mizuho
Pfizer price target raised to $43 from $38 at Mizuho
BNTX BioNTech
$83.17 /

-2.23 (-2.61%)

07/21/20
Fly Intel: Top five analyst upgrades
PFE Pfizer
$38.38 /

+0.025 (+0.07%)

BNTX BioNTech
$83.17 /

-2.23 (-2.61%)

  • 23
    Jul
  • 06
    Feb
  • 10
    Oct
PFE Pfizer
$38.38 /

+0.025 (+0.07%)

BNTX BioNTech
$83.17 /

-2.23 (-2.61%)

PFE Pfizer
$38.38 /

+0.025 (+0.07%)

BNTX BioNTech
$83.17 /

-2.23 (-2.61%)

PFE Pfizer
$38.38 /

+0.025 (+0.07%)

BNTX BioNTech
$83.17 /

-2.23 (-2.61%)

Hot Stocks
Pfizer announces CROWN study of Lorbrena meets PFS primary endpoint » 08:02
08/05/20
08/05
08:02
08/05/20
08:02
PFE

Pfizer

$38.38 /

+0.025 (+0.07%)

Pfizer announced that the…

Pfizer announced that the Phase 3 CROWN study of Lorbrena in people with previously untreated advanced anaplastic lymphoma kinase, or ALK-positive, non-small cell lung cancer, or NSCLC, met its primary endpoint by demonstrating significantly improved progression-free survival, or PFS, as compared to Xalkori. The results were reviewed by an independent Data Monitoring Committee, or DMC, at a planned interim analysis. The safety profile for lorlatinib and crizotinib were consistent with what has been previously seen in clinical trials. The results from CROWN will be submitted for presentation at an upcoming medical congress.

ShowHide Related Items >><<
PFE Pfizer
$38.38 /

+0.025 (+0.07%)

PFE Pfizer
$38.38 /

+0.025 (+0.07%)

08/03/20 Jefferies
Moderna's Phase 3 data on COVID vaccine could come by October, says Jefferies
07/30/20 BofA
BofA says hard to compare Moderna COVID data to competing preclinical data
07/30/20 Morgan Stanley
Pfizer price target raised to $42 from $36 at Morgan Stanley
07/30/20 Mizuho
Pfizer price target raised to $43 from $38 at Mizuho
PFE Pfizer
$38.38 /

+0.025 (+0.07%)

PFE Pfizer
$38.38 /

+0.025 (+0.07%)

PFE Pfizer
$38.38 /

+0.025 (+0.07%)

PFE Pfizer
$38.38 /

+0.025 (+0.07%)

Tuesday
Periodicals
COVID-19 vaccine candidates impress, but investors wary, WSJ reports » 06:07
08/04/20
08/04
06:07
08/04/20
06:07
MRNA

Moderna

$77.98 /

+3.88 (+5.24%)

, PFE

Pfizer

$38.36 /

-0.125 (-0.32%)

Potential COVID-19…

Potential COVID-19 vaccines from Moderna (MRNA), Pfizer (PFE) and its partner BioNTech are drawing early enthusiasm, but investors are wary of upping stakes because valuations have soared, The Wall Street Journal's Gregory Zuckerman and Joseph Walker report. Though vaccines based on messenger RNA technology appear to be performing best at eliciting antibodies that can potentially neutralize the coronavirus, the early-stage studies that have produced results so far weren't designed to show whether the vaccines truly protect people from COVID-19, only to test safety and immune responses. Reference Link

ShowHide Related Items >><<
PFE Pfizer
$38.36 /

-0.125 (-0.32%)

MRNA Moderna
$77.98 /

+3.88 (+5.24%)

MRNA Moderna
$77.98 /

+3.88 (+5.24%)

08/03/20 Jefferies
Moderna's Phase 3 data on COVID vaccine could come by October, says Jefferies
07/30/20 BofA
BofA says hard to compare Moderna COVID data to competing preclinical data
07/27/20 Piper Sandler
Piper reiterates $134 Moderna target on start of Phase III vaccine trial
07/27/20 BMO Capital
Moderna price target lowered to $94 from $112 at BMO Capital
PFE Pfizer
$38.36 /

-0.125 (-0.32%)

07/30/20 Morgan Stanley
Pfizer price target raised to $42 from $36 at Morgan Stanley
07/30/20 Mizuho
Pfizer price target raised to $43 from $38 at Mizuho
PFE Pfizer
$38.36 /

-0.125 (-0.32%)

MRNA Moderna
$77.98 /

+3.88 (+5.24%)

  • 19
    May
  • 12
    Feb
PFE Pfizer
$38.36 /

-0.125 (-0.32%)

MRNA Moderna
$77.98 /

+3.88 (+5.24%)

PFE Pfizer
$38.36 /

-0.125 (-0.32%)

MRNA Moderna
$77.98 /

+3.88 (+5.24%)

PFE Pfizer
$38.36 /

-0.125 (-0.32%)

MRNA Moderna
$77.98 /

+3.88 (+5.24%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.